Evidence map›Paper›PMID 17028428›Full record

ArticleDevelopmental neuroscience2006

The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents.

Suhail Kasim, Bonita L Blake, Xueliang Fan, Elena Chartoff, Kiyoshi Egami, George R Breese, Ellen J Hess, H A Jinnah

Open access · bronzeAbstract read
In one paragraph

Article in Developmental neuroscience, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Hypervitaminosis DIranian journal of veterinary research · 2017
    Article
  5. Article
  6. Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?Movement disorders : official journal of the Movement Disorder Society · 2011
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Suhail KasimDepartment of Neurology, Johns Hopkins University, Baltimore, MD 21287, USA.
Bonita L Blake
Xueliang Fan
Elena Chartoff
Kiyoshi Egami
George R Breese
Ellen J Hess
H A Jinnah
Johns Hopkins University · USUniversity of North Carolina at Chapel Hill · USHarvard University · US

Funding

Neurobiology of Self-Injurious BehaviorR01HD039795 · NICHD · JOHNS HOPKINS UNIVERSITY · PI JINNAH, HYDER A · 2002 to 2005
$1.2M
NICHD NIH HHS HD39795NICHD NIH HHS R01 HD039795
6 · The paper itself

Abstract

In rodents, activation of L-type calcium channels with +/-BayK 8644 causes an unusual behavioral syndrome that includes dystonia and self-biting. Prior studies have linked both of these behaviors to dysfunction of dopaminergic transmission in the striatum. The current studies were designed to further elucidate the relationship between +/-BayK 8644 and dopaminergic transmission in the expression of the behavioral syndrome. The drug does not appear to release presynaptic dopamine stores, since microdialysis of the striatum revealed dopamine release was unaltered by +/-BayK 8644. In addition, the behaviors were preserved or even exaggerated in mice or rats with virtually complete dopamine depletion. On the other hand, pretreatment of mice with D(3) or D(1/5) dopamine receptor antagonists attenuated the behavioral effects of +/-BayK 8644, while pretreatment with D(2) or D(4) antagonists had no effect. In D(3) receptor knockout mice, +/-BayK 8644 elicited both dystonia and self-biting, but these behaviors were less severe than in matched controls. In D(1) receptor knockout mice, behavioral responses to +/-BayK 8644 appeared exaggerated. These results argue that the behavioral effects of +/-BayK 8644 are not mediated by a presynaptic influence. Instead, the behaviors appear to result from a postsynaptic activation of the drug, which does not require but can be modified by D(3) or D(1/5) receptors.

Indexed as

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAnimalsCalcium Channel AgonistsCalcium Channels, L-TypeCentral Nervous System StimulantsCorpus StriatumDisease Models, AnimalDopamineDopamine AntagonistsDystoniaFemaleMaleMiceMice, Inbred C57BLMice, KnockoutRats3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterCalcium Channel AgonistsCalcium Channels, L-TypeCentral Nervous System StimulantsDopamineDopamine AntagonistsReceptors, DopamineReceptors, Dopamine D1Receptors, Dopamine D3

Identifiers

PMID17028428
PMCPMC2951315
OpenAlexW2067197705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.